Harvard Bioscience, Inc..
HBIO.US | Manufacture of measuring, testing, navigating and control equipment
Harvard Bioscience, Inc. is a global developer, manufacturer, and seller of a broad range of solutions to advance life science. The company's products are used by researchers in academic institutions, pharmaceutical companies, and government laboratories. Harvard Bioscience offers a wide array of in...Show More
Better Health for All
20
Harvard Bioscience's core products, which include instruments, consumables, and services, are essential tools for basic research, drug discovery, and preclinical development, enabling advancements in life science. The company's mission is to achieve better health for all.
1
Its products support research into critical areas such as vaccines and immunotherapies for infectious diseases and oncology, neurological conditions affecting over three billion people worldwide (including dementia, epilepsy, stroke, migraine, Alzheimer's, and schizophrenia), and the health impacts of wildfire smoke (respiratory, cardiovascular, and metabolic issues).
2
There is no evidence of any products with negative health outcomes. The company is committed to supporting researchers in their quest to prevent, treat, and cure neurological diseases, offering a comprehensive suite of solutions for research needs.
3
Harvard Bioscience offers a comprehensive suite of solutions designed to meet research needs, from high-throughput cellular applications to recording data in freely moving animals.
4
The company's products are also used in research to develop targeted interventions for health issues like sleep-disordered breathing to slow Alzheimer's progression, and to understand and mitigate the health impacts of wildfire smoke, which is framed as a growing public health crisis.
5
The company's operations do not directly involve preventative health or treatment activities, nor do they directly affect mental health outcomes, or health crisis response, but its products support research in these areas.
Fair Money & Economic Opportunity
0
No evidence available to assess Harvard Bioscience, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
20
The CEO to median employee pay ratio was 28:1 in FY2025.
1
The company had 355 employees as of December 31, 2024, with 330 being full-time.
2
As of December 31, 2023, the company had 416 employees, including 391 full-time and 25 part-time.
3
Some employees in Europe have statutory collective bargaining rights.
4
The company has never experienced a general work stoppage or strike, and management believes relations with employees are good.
5
The company makes employment decisions without regard to age, color, national origin, citizenship status, physical or mental disability, race, religion, creed, gender, sex, sexual orientation, gender identity and/or expression, genetic information, marital status, status with regard to public assistance, veteran and military status or any other characteristic protected by federal, state or local law.
6
The company also takes steps to employ and advance qualified protected veterans and individuals with disabilities.
7
Fair Trade & Ethical Sourcing
0
No evidence available to assess Harvard Bioscience, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, quantifiable evidence was found in the provided articles to score any of the KPIs against the 'Honest & Fair Business' value. Information regarding a Nasdaq non-compliance related to the audit committee's independence did not provide the percentage of the entire board free from material conflicts of interest, which is required by the rubric for scoring.
1
Kind to Animals
-20
Harvard Bioscience (HBIO.US) has a policy committing to the humane and responsible treatment of animals used for research, testing, or education, supported by an Institutional Animal Care and Use Committee (IACUC) and an ethics hotline.
1
However, this policy is vague and does not explicitly commit to reduction or prohibition of non-essential testing. There is no specific data on the number of animals used annually by HBIO.US, nor is there information on the percentage of its R&D budget invested in animal-free technologies.
2
While HBIO offers in vitro solutions that can help other labs provide New Approach Methodologies (NAM) data, there is no evidence of its own participation in multi-stakeholder initiatives to develop industry-wide animal-free testing and sourcing standards.
3
No War, No Weapons
0
The provided articles discuss federal funding cuts for Harvard University's defense-related projects. Both articles explicitly state that they do not contain data relevant to HBIO.US or the 'No War, No Weapons' ethical value.
1
Therefore, no KPIs can be assessed for HBIO.US based on the evidence provided.
Planet-Friendly Business
0
No specific, concrete data points are available for Harvard Bioscience Inc. (HBIO.US) regarding its planet-friendly business practices. The provided articles primarily discuss the sustainability efforts of Harvard Management Company (HMC) and Harvard University. explicitly states that "no specific metrics related to HBIO.US are provided."
1
directly confirms that "No sustainability reports are currently available on ResponsibilityReports.com for Harvard Bioscience Inc.,"
2
concluding that "Insufficient data is available to provide a summary of HBIO's sustainability performance."
3
Respect for Cultures & Communities
0
No specific data or evidence regarding HBIO.US's performance on any of the 'Respect for Cultures & Communities' KPIs was found in the provided articles. The articles discuss general concepts related to cultural rights and community engagement, or company policies unrelated to the specified KPIs, but do not offer concrete facts, numbers, or actions taken by HBIO.US in this area.
Safe & Smart Tech
0
No evidence available to assess Harvard Bioscience, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No quantitative data, regulatory actions, violations, fines, certifications, awards, or recognitions related to zero waste and sustainable products were found in the provided article content.
1
The article is a placeholder and contains no relevant information for assessment.
2